Results 141 to 150 of about 1,936,479 (187)

MAPTrans: mutual attention transformer with dynamic meta-path pruning for drug repositioning. [PDF]

Brief Bioinform
Ding S, Niu D, Wang X, Zhang Z, Zhang Q, Xiao J, Li Z.   +6 more
europepmc   +1 more source

A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome. [PDF]

Biomed Res Int
Al-Madhagi H.
europepmc   +1 more source

Exploring the shared gene signatures between rheumatoid arthritis and type 2 diabetes and their implication for drug repositioning on bioinformatics analysis. [PDF]

Medicine (Baltimore)
Qu X, Zuo X, Du H, Chen Y, Zhang Q, Peng H, Ma K, Zhang F, Cai Y, Tan L, Deng H, Chen X.   +11 more
europepmc   +1 more source

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies. [PDF]

J Transl Med
Salvati A, Melone V, Giordano A, Lamberti J, Palumbo D, Palo L, Rea D, Memoli D, Simonis V, Alexandrova E, Silvestro F, Rizzo F, Weisz A, Tarallo R, Nassa G.   +14 more
europepmc   +1 more source

[Drug repositioning prediction based on dynamic feature learning on heterogeneous graphs]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhu H, Guo Y, Xin X, Li C, Zhou D.
europepmc   +1 more source

Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning. [PDF]

Biology (Basel)
Wang Y, Wang Y, Hu Y, Wang J.
europepmc   +1 more source

A systematic computational analysis of pharmacological options in neuroinflammatory-induced autism spectrum disorder in children: A potential for drug repositioning. [PDF]

J Biol Methods
Ismail M, Aananou S, Foguem C, Guinhouya KM, Dossou GT, Boudis F, Tchedre K, Vilhelm C, Guinhouya BC, Zitoun D.   +9 more
europepmc   +1 more source

Repositioning Drugs for Psychiatry.

Avicenna journal of medical biotechnology
openaire   +1 more source

Drug repositioning: a brief overview. [PDF]

Journal of Pharmacy and Pharmacology, 2020
International audienceAbstract Objectives Drug repositioning, that is, the use of a drug in an indication other than the one for which it was initially marketed, is a growing trend.
Christophe Rochais, Jean-Pierre Jourdan, Patrick Dallemagne   +2 more
exaly   +6 more sources

Structure-based drug repositioning: Potential and limits [PDF]

Seminars in Cancer Biology, 2021
Drug repositioning, the assignment of new therapeutic purposes to known drugs, is an established strategy with many repurposed drugs on the market and many more at experimental stage.
Daniele Parisi, Melissa F. Adasme, Michael Schroeder   +2 more
exaly   +2 more sources